Lista de obras - John L Reagan - Dominio Público Uruguay

Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report.

artículo científico publicado en 2016

Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†

scientific article published on 11 September 2020

Adoptive immunotherapy for myeloid malignancies.

artículo científico publicado en 2014

Advances in cellular therapy for the treatment of leukemia

artículo científico

Antibiotic use during cytarabine consolidation in acute myeloid leukemia

artículo científico publicado en 2020

Bone marrow-specific loss of induces myeloproliferative neoplasm with features resembling human myelofibrosis

artículo científico publicado en 2018

Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.

artículo científico publicado en 2015

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.

artículo científico publicado en 2018

Cellular immunotherapy for refractory hematological malignancies

artículo científico publicado en 2013

Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.

artículo científico publicado en 2016

Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base

scientific article published on 09 July 2019

Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing

artículo científico publicado en 2014

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

artículo científico publicado en 2003

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis

artículo científico publicado en 2022

Extracellular vesicles in leukemia

artículo científico publicado en 2017

Hodgkin lymphoma mimicking lung abscess

artículo científico publicado en 2016

IgM myeloma: A multicenter retrospective study of 134 patients

artículo científico publicado en 2017

Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?

artículo científico publicado en 2017

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies

artículo científico publicado en 2012

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

artículo científico publicado en 2004

Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses

article

Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas

artículo científico publicado en 2017

Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.

artículo científico publicado en 2014

Marrow cell genetic phenotype change induced by human lung cancer cells

artículo científico publicado en 2011

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

artículo científico publicado en 2004

Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality

artículo científico

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia

artículo científico publicado en 2015

Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies

artículo científico publicado en 2013

Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia

artículo científico publicado en 2014

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia ⬇️

artículo científico publicado el 1 de febrero de 2011

Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma

artículo científico publicado en 2019

Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma

scientific article published on 11 September 2020

Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia

artículo científico publicado en 2018

Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.

artículo científico publicado en 2011

Plasmablastic Lymphoma: A Systematic Review ⬇️

artículo científico publicado el 22 de marzo de 2011

Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study

artículo científico publicado en 2015

Primary refractory Hodgkin lymphoma: Limited options and poor survival-but not always

artículo científico publicado en 2014

Rhomboid glossitis in disseminated CMV infection

artículo científico publicado en 2017

The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody-drug conjugate for the treatment of newly diagnosed acute myeloid leukemia

article published in 2018

Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas

artículo científico publicado en 2018

Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma

scientific article published on 30 September 2019

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

artículo científico publicado en 2013

Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies

artículo científico

Why is My Patient Neutropenic?

artículo científico publicado en 2012

Lista de obras de John L Reagan

Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report.

Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†

Adoptive immunotherapy for myeloid malignancies.

Advances in cellular therapy for the treatment of leukemia

Antibiotic use during cytarabine consolidation in acute myeloid leukemia

Bone marrow-specific loss of induces myeloproliferative neoplasm with features resembling human myelofibrosis

Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.

Cellular immunotherapy for refractory hematological malignancies

Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.

Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base

Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis

Extracellular vesicles in leukemia

Hodgkin lymphoma mimicking lung abscess

IgM myeloma: A multicenter retrospective study of 134 patients

Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses

Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas

Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.

Marrow cell genetic phenotype change induced by human lung cancer cells

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia

Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies

Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia ⬇️

Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma

Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma

Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia

Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.

Plasmablastic Lymphoma: A Systematic Review ⬇️

Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study

Primary refractory Hodgkin lymphoma: Limited options and poor survival-but not always

Rhomboid glossitis in disseminated CMV infection

The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody-drug conjugate for the treatment of newly diagnosed acute myeloid leukemia

Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas

Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies

Why is My Patient Neutropenic?